Advertisement
Table 1 Baseline Characteristics
| Intervention (n = 499) | Control (n = 500) | |
|---|---|---|
| Agea | 51.0 (12.1) | 49.5 (11.5) |
| White | 468 (93.8) | 469 (93.8) |
| Female | 201 (40.3) | 203 (40.6) |
| Ischemic heart disease | 29 (5.8) | 19 (3.8) |
| Cerebrovascular disease | 19 (3.8) | 17 (3.4) |
| On BP medications | 346 (69.3) | 353 (70.6) |
| BMI, kg/m2 | 34.5 (9.0) | 34.9 (8.1) |
| SBP, mmHg | 139.5 (14.2) | 140.1 (13.9) |
| DBP, mmHg | 86.3 (9.6) | 86.0 (8.7) |
| eGFR, ml/min/1.73m2 | ||
| ≥ 60 | 397 (79.6) | 405 (81.0) |
| 15–60 | 13 (2.6) | 9 (1.8) |
| Missing | 89 (17.8) | 86 (17.2) |
